Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of lopinavir/r in monotherapy and
peg-interferon plus ribavirin for the control of both HIV and HCV infection respectively
after 12 months of active treatment for HCV.